Daratumumab is effective in the relapsed or refractory...

  • Main
  • 2019 / 11
  • Daratumumab is effective in the relapsed or refractory...

Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population

Van de Wyngaert, Zoe, Carpentier, Benjamin, Pascal, Laurent, Lionne‐Huyghe, Pauline, Leduc, Isabelle, Srour, Micha, Vasseur, Michele, Demarquette, Helene, Terriou, Louis, Herbaux, Charles, Manier, Sal
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.16282
Date:
November, 2019
File:
PDF, 149 KB
2019
Conversion to is in progress
Conversion to is failed